Corporate Banner
Satellite Banner
Biologics & Bioprocessing
Scientific Community
Become a Member | Sign in

  News Archive

Baxalta, Symphogen Establish Collaboration
Wednesday, January 06, 2016
Partnership aims to advance development of novel immune checkpoint therapies as Baxalta expands oncology leadership in orphan diseases.

Study Shows High Frequency of Spontaneous Mutation in Ebola Virus
Wednesday, January 06, 2016
Mutation rate of Ebola virus could prove a useful therapy.

Merus, Gustave Roussy Form Strategic Collaboration
Tuesday, January 05, 2016
Merus B.V.and Institut Gustave Roussy has announced entry into a strategic collaboration to jointly develop bispecific antibodies for therapeutic immuno-oncology applications.

Creating Safer Polio Vaccine Strains for the Post-Eradication Era
Tuesday, January 05, 2016
A study reports the generation of new vaccine strains that appear both effective and unable to cause disease after accidental or intended release.

Immune Pharma Announces Exclusive License
Monday, January 04, 2016
New technology will allow for the development of innovative drug candidates targeting immune checkpoints.

Cell-Free Protein Synthesis is Potential Lifesaver
Monday, January 04, 2016
Lives of soldiers and others injured in remote locations could be saved with a cell-free protein synthesis system developed at the Department of Energy’s Oak Ridge National Laboratory.

Scientists Wield Plant Viruses Against Deadly Human Disease
Monday, January 04, 2016
Case Western Reserve University researchers hope to take a healthy salad up a level by growing a vaccine for an aggressive form of breast cancer in leafy greens.

Agenus Acquires PhosImmune
Monday, January 04, 2016
Offers the potential for rapid advancement of clinical programs and creation of new partnerships.

Ligand to Acquire OMT
Monday, December 21, 2015
Ligand Pharmaceuticals Incorporated and OMT, Inc. (Open Monoclonal Technology) announce the signing of agreements for Ligand to acquire OMT, Inc., a leader in genetic engineering of animals for the generation of human therapeutic antibodies through its OmniAb™ platform.

<< 5 6 7 8 9 10 11 >>
Showing Results 71 - 80 of 1785

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,900+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,200+ scientific videos